Validating a Simple Scoring System to Predict Malignancy and Invasiveness of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Autor: | Song C. Kim, D.J. Han, Kwan T. Park, Sang H. Shin, Jae B. Park, Young Ho Kim |
---|---|
Rok vydání: | 2010 |
Předmět: |
Adult
Male Pathology medicine.medical_specialty Pancreatic disease Malignancy Metastasis Predictive Value of Tests Risk Factors Biomarkers Tumor medicine Humans Neoplasm Invasiveness Aged Neoplasm Staging Retrospective Studies Chi-Square Distribution Intraductal papillary mucinous neoplasm business.industry Carcinoma in situ Cancer Middle Aged medicine.disease Adenocarcinoma Mucinous Carcinoma Papillary Survival Rate medicine.anatomical_structure Pancreatitis Female Surgery Tomography X-Ray Computed Pancreas business Carcinoma in Situ Carcinoma Pancreatic Ductal |
Zdroj: | World Journal of Surgery. 34:776-783 |
ISSN: | 1432-2323 0364-2313 |
DOI: | 10.1007/s00268-010-0416-5 |
Popis: | The objective of the present study was to identify reliable preoperative factors predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm (IPMN) of the pancreas and the effectiveness of a diagnostic scoring system based on these factors.Between August 1994 and December 2007, 204 patients underwent pancreatic resection for IPMN at a single institute. Medical records were reviewed retrospectively, and a new diagnostic scoring system for predicting malignant IPMN preoperatively was designed.Univariate analysis revealed nine significant predictors of both malignant and invasive IPMN: ageor =60 years, history of pancreatitis, presence of mural nodule(s), diameter of main pancreatic duct (MPD)6 mm, main duct or mixed type, total bilirubin1.2 mg/dl, CA-19-937 U/ml, tumor location in the pancreatic head, and tumor size30 mm. Multivariate analysis showed that age, pancreatitis, mural nodule(s), and MPD diameter were independent predictors of invasive IPMN, and that all these parameters, plus elevated carbohydrate antigen-19-9 (CA-19-9), were independent predictors of malignant IPMN. A scoring system based on these five factors, each assigned 1 point, and with a cut-off of 3 points, could predict malignant IPMN with a sensitivity of 50.7% and a specificity of 90.1%. The 5-year survival rates of patients with benign and malignant IPMN were 95.0% and 64.0%, respectively.Our scoring system using five independent factors (ageor =60 years, history of pancreatitis, presence of mural nodule(s), elevated level of CA-19-9, and MPD diameter6 mm) may be helpful for predicting malignancy and postoperative survival. |
Databáze: | OpenAIRE |
Externí odkaz: |